114 related articles for article (PubMed ID: 11392536)
21. Sphingolactones: selective and irreversible inhibitors of neutral sphingomyelinase.
Wascholowski V; Giannis A
Angew Chem Int Ed Engl; 2006 Jan; 45(5):827-30. PubMed ID: 16365835
[No Abstract] [Full Text] [Related]
22. Soluble Fas ligand activates the sphingomyelin pathway and induces apoptosis in luteal steroidogenic cells independently of stress-activated p38(MAPK).
Pru JK; Hendry IR; Davis JS; Rueda BR
Endocrinology; 2002 Nov; 143(11):4350-7. PubMed ID: 12399431
[TBL] [Abstract][Full Text] [Related]
23. Interaction of sphingomyelinase with sphingomyelin analogs modified at the C-1 and C-3 positions of the sphingosine backbone.
Lister MD; Ruan ZS; Bittman R
Biochim Biophys Acta; 1995 Apr; 1256(1):25-30. PubMed ID: 7742352
[TBL] [Abstract][Full Text] [Related]
24. Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.
Gerritsen ME; Shen CP; Perry CA
Am J Pathol; 1998 Feb; 152(2):505-12. PubMed ID: 9466577
[TBL] [Abstract][Full Text] [Related]
25. Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes.
Zeng C; Lee JT; Chen H; Chen S; Hsu CY; Xu J
J Neurochem; 2005 Aug; 94(3):703-12. PubMed ID: 16033420
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.
Klar R; Levade T; Gatt S
Clin Chim Acta; 1988 Sep; 176(3):259-67. PubMed ID: 2846208
[TBL] [Abstract][Full Text] [Related]
27. [Synthesis of phosphonate analogs of sphingomyelins and preparation of an affinity sorbent for sphingomyelinase purification].
Tazabekova NT; Bushnev AS; Kakimzhanova ZhA; Zvonkova EN; Evstigneeva RP
Bioorg Khim; 1987 May; 13(5):648-53. PubMed ID: 3040014
[TBL] [Abstract][Full Text] [Related]
28. Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833.
Bezombes C; Maestre N; Laurent G; Levade T; Bettaïeb A; Jaffrézou JP
FASEB J; 1998 Jan; 12(1):101-9. PubMed ID: 9438415
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of three novel scyphostatin analogues as neutral sphingomyelinase inhibitors.
Pitsinos EN; Wascholowski V; Karaliota S; Rigou C; Couladouros EA; Giannis A
Chembiochem; 2003 Nov; 4(11):1223-5. PubMed ID: 14613115
[No Abstract] [Full Text] [Related]
30. Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors.
Imagawa H; Oda M; Takemoto T; Yamauchi R; Yoshikawa T; Yamamoto H; Nishizawa M; Takahashi H; Hashimoto M; Yabiku K; Nagahama M; Sakurai J
Bioorg Med Chem Lett; 2010 Jul; 20(13):3868-71. PubMed ID: 20627555
[TBL] [Abstract][Full Text] [Related]
31. Trk receptors need neutral sphingomyelinase activity to promote cell viability.
Candalija A; Cubí R; Ortega A; Aguilera J; Gil C
FEBS Lett; 2014 Jan; 588(1):167-74. PubMed ID: 24316227
[TBL] [Abstract][Full Text] [Related]
32. Comparative hydrolysis of sphingomyelin and 2-N-(hexadecanoyl)-amino-4-nitrophenyl-phosphorylcholine by normal human brain homogenate at acid and neutral pH.
Levade T; Salvayre R; Douste-Blazy L
J Neurochem; 1983 Jun; 40(6):1762-4. PubMed ID: 6304255
[TBL] [Abstract][Full Text] [Related]
33. Identification of three competitive inhibitors for membrane-associated, Mg2+-dependent and neutral 60 kDa sphingomyelinase activity.
Kim SK; Jung SM; Ahn KH; Jeon HJ; Lee DH; Jung KM; Jung SY; Kim DK
Arch Pharm Res; 2005 Aug; 28(8):923-9. PubMed ID: 16178418
[TBL] [Abstract][Full Text] [Related]
34. Chlorogentisylquinone, a new neutral sphingomyelinase inhibitor, produced by a marine fungus.
Uchida R; Tomoda H; Arai M; Omura S
J Antibiot (Tokyo); 2001 Nov; 54(11):882-9. PubMed ID: 11827029
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor-alpha induces apoptosis in immortalized hypothalamic neurons: involvement of ceramide-generating pathways.
Sortino MA; Condorelli F; Vancheri C; Canonico PL
Endocrinology; 1999 Oct; 140(10):4841-9. PubMed ID: 10499544
[TBL] [Abstract][Full Text] [Related]
36. Gentamicin Targets Acid Sphingomyelinase in Cancer: The Case of the Human Gastric Cancer NCI-N87 Cells.
Albi E; Cataldi S; Ceccarini MR; Conte C; Ferri I; Fettucciari K; Patria FF; Beccari T; Codini M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489901
[TBL] [Abstract][Full Text] [Related]
37. Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima.
Nara F; Tanaka M; Masuda-Inoue S; Yamasato Y; Doi-Yoshioka H; Suzuki-Konagai K; Kumakura S; Ogita T
J Antibiot (Tokyo); 1999 Jun; 52(6):531-5. PubMed ID: 10470676
[TBL] [Abstract][Full Text] [Related]
38. Biological activities of alpha-mangostin derivatives against acidic sphingomyelinase.
Hamada M; Iikubo K; Ishikawa Y; Ikeda A; Umezawa K; Nishiyama S
Bioorg Med Chem Lett; 2003 Oct; 13(19):3151-3. PubMed ID: 12951083
[TBL] [Abstract][Full Text] [Related]
39. A spectrophotometric method for determination of sphingomyelinase.
Gatt S; Dinur T; Barenholz Y
Biochim Biophys Acta; 1978 Sep; 530(3):503-7. PubMed ID: 212111
[TBL] [Abstract][Full Text] [Related]
40. [Correction of age-related changes in sphingolipid content in rat tissues by acid sphingomyelinase inhibition].
Har'kavenko VV; Storozhenko GB; Krasnikova OM; Babenko NO
Fiziol Zh (1994); 2012; 58(1):56-60. PubMed ID: 22590738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
